Home  »  Companies   »  Catalysts for shares to shoot up: AIkido Pharma In...

Catalysts for shares to shoot up: AIkido Pharma Inc. (AIKI)

Related Topics

Historical Earnings Surprises and Revenue Forecasts

It appears that the average earnings per share estimate for the current quarter (ending in Mar 2014) is $0. This is an average of 0 analysts’ earnings, where the high earnings per share estimate is $0 and the low earnings per share estimate is $0. According to 1 analyst estimates, an average revenue estimate of $6.5M is projected for the current quarter with a high revenue estimate of $6.5M and a low estimate of $6.5M.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!


The latest trade, Performances and Moving Averages give us the following Picture

The share price of AIkido Pharma Inc. (NASDAQ:AIKI) dipped -2.78% to close Wednesday’s market session at $1.05, lower as compared to yesterday’s close. The stock price fluctuated between $1.03 and $1.09 throughout the trading session with the volume trading being 3800867 shares, which represented a significant variation when compared to the three months average volume of 5.94 million shares. The firm’s stock price fluctuated -4.55% within the last five trades and 21.04% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 67.89% in the last 6 months and -11.02% was subtracted to its value over the previous 3 months. AIKI stock is trading at a margin of 1.25%, 3.57% and 14.81% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

As of the close of trading, AIKI deals in the Healthcare domain. The stock is trading -58.82 percent below its 52-week high and 125.52 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -1.77. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

What Does AIkido Pharma Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?

The stock’s market cap achieved a total value of $103.90 million as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The firm managed a Price-to-Book ratio of 0.61, which equates the market value of a stock with its book value.

Is Insider Trading a Real Thing?

Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.10 percent of AIkido Pharma Inc. shares are owned by insiders, and 16.00 percent are held by financial institutions. Hayes Anthony, the CEO at AIkido Pharma Inc. (AIKI) has bought 10,000 shares of firm on May 03 at a price of $0.99 against the total amount of $9900.0. In another inside trade, Hayes Anthony, CEO of AIkido Pharma Inc. (NASDAQ:AIKI) bought 10,000 shares of the firm on Apr 29 for a total worth of $9900.0 at a price of $0.99. An inside trade which took place on Apr 22, CEO of AIkido Pharma Inc. Hayes Anthony bought 10,000 shares of firm against total price of $9300.0 at the cost of $0.93 per share.

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:
Sign up for our FREE Newsletter and get:

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.